EDS: Validation of a Diagnostic Tool for Postprandial Hypoglycaemia in Patients After Roux en Y Gastric Bypass Surgery

Sponsor
University Ghent (Other)
Overall Status
Completed
CT.gov ID
NCT03406312
Collaborator
(none)
40
1
35.1
1.1

Study Details

Study Description

Brief Summary

Roux-en-Y gastric bypass (RYGB) leads to weight reduction but has also some unwanted side effects. A part of this population will develop postprandial reactive hypoglycemia (PPRH). At this moment no validated diagnostic tool exists for PPRH. The aim of this study is to prove an association between the Sigstad´s Score and the lowest postprandial glucose level in patients after RYGB surgery. This is investigated using a liquid mixed meal tolerance test (LMMTT). As a secondary hypothesis, associations between Edinburgh Hypoglycemia Scale (EHS) and postprandial glucose levels are investigated. Furthermore, changes of insulin and GLP-1 levels during the test are analysed. Patient characteristics including co-morbidities are studied as possible influencing parameters. Moreover, a healthy control group is included to validate the results. Finally, a flowchart/diagnostic method will be proposed for diagnosing patients who had a RYBG surgery with symptoms suggestive of PPRH. Besides the LMMTT, participants at the Ghent University Hospital will undergo additional tests such as a solid mixed meal tolerance test (SMMTT) and continuous glucose monitoring (CGM). Associations between Sigstad Score, EHS and the lowest glucose measured during CGM and SMMTT will be investigated and compared to the results of the LMMTT.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Post Prandial Hypoglycemia test

Study Design

Study Type:
Observational
Actual Enrollment :
40 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
European Dumping Study: Validation of a Diagnostic Tool for Postprandial Hypoglycaemia in Patients After Roux en Y Gastric Bypass Surgery
Actual Study Start Date :
Jun 1, 2017
Actual Primary Completion Date :
May 5, 2020
Actual Study Completion Date :
May 5, 2020

Arms and Interventions

Arm Intervention/Treatment
Gastric Bypass Surgery population

liquid mixed meal tolerance test, solid mixed meal tolerance test, continuous glucose monitoring

Diagnostic Test: Post Prandial Hypoglycemia test
three test assessing hypoglycemia will be used: liquid mixed meal tolerance test, solid mixed meal tolerances test, continuous glucose monitoring

Control population

liquid mixed meal tolerance test, solid mixed meal tolerance test, continuous glucose monitoring

Diagnostic Test: Post Prandial Hypoglycemia test
three test assessing hypoglycemia will be used: liquid mixed meal tolerance test, solid mixed meal tolerances test, continuous glucose monitoring

Outcome Measures

Primary Outcome Measures

  1. Association between Sigstad's score and the lowest postprandial glucose levels [end 2018]

    we are investigating whether there is an association between the Sigtad's score and the lowest glucose levels postprandialy

Secondary Outcome Measures

  1. Association between Ediinburgh Hypoglycemia scale and the lowest postprandial glucose levels [end 2018]

    we are investigating whether there is an association between the Ediinburgh Hypoglycemia scale and the lowest glucose levels postprandialy

  2. flow chart for diagnosis of postprandial reactive hypoglyceamia [end 2018]

    Proposing a flowchart/diagnostic method for the diagnosis of postprandial reactive hypoglycemic syndrome which occurs in people who underwent a gastric bypass surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • for GBS group: primary GBS, 1-5 years post surgery

  • for control group: 10 subjects BMI 18-25kg/m² and 10 subjects BMI >30 kg/m²

Exclusion Criteria:
  • Antidiabetic medication (oral or injectable), somatostatin analogs

  • Use of systemic corticosteroids

  • for GBS group: Any surgery after RYGB affecting anatomic integrity of the bypass, e.g. banding, conversion of the proximal and/or distal anastomosis

  • for GBS group: Any surgery before RYGB affecting anatomic integrity of the bypass, e.g. banding, conversion of the proximal and/or distal anastomosis, sleeve gastrectomy

  • Known renal insufficiency: CDK ≥ 4

  • Known liver cirrhosis

  • Known cardiovascular risk: NYHA ≥ III

  • Mental incapacity

  • Language barriers with inability to communicate with research staff

  • Anemia Hb < 6.2 mmol/l (10.0 g/dl)

  • Cancer within < 5 years

  • Pregnancy

  • Allergy to the Fresubin E

  • Allergy to components of the solid mixed meal (white bread, cheese spread, margarine, orange)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Endocrinology, UZ Ghent Hospital Ghent Belgium 9000

Sponsors and Collaborators

  • University Ghent

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Ghent
ClinicalTrials.gov Identifier:
NCT03406312
Other Study ID Numbers:
  • B670201731703
First Posted:
Jan 23, 2018
Last Update Posted:
Dec 1, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Ghent
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 1, 2021